[Remimazolam-Update on basic pharmacologic principles and clinical potential]. / Remimazolam Update zu Grundlagen und klinischem Potenzial.
Anaesthesiologie
; 2024 Aug 19.
Article
em De
| MEDLINE
| ID: mdl-39158735
ABSTRACT
In recent years the still relatively new short-acting benzodiazepine remimazolam has been approved and clinically implemented in several countries and regions. Remimazolam is also now approved in the EU and the market launch in Germany is expected in the not too distant future. This is therefore a good point in time to summarize the current evidence for various areas of application, including general anesthesia, sedation and intensive care medicine as well as different dosing schemes.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
De
Revista:
Anaesthesiologie
Ano de publicação:
2024
Tipo de documento:
Article